Stony Brook Medicine is on a path to becoming a world-class institution, a national leader in academic medicine and the first choice in healthcare for patients on Long Island. Major changes within the past year are signs that that we are beginning to soar. In place is a set of new lead faculty with national reputations as innovators in research, education and clinical care. Also, a tremendous influx of generous donations and grants – a total of nearly $200 million led by the historic Simons Gift of $150 million – is giving us the resources to think and build big.
In this edition of Medicine Today, articles will inform you of the growth and plans for Stony Brook Medicine. The School of Medicine’s Strategic Plan, which includes the call to recruit 80 new faculty to bolster opportunities to increase translating basic science to new diagnoses and treatments for many diseases, is also central to training more medical students, and frames the big picture of our ambitious direction. The creation of the Medical and Research Translation (MART) center will serve as a collaborative research hub with a focus on cancer infectious disease, neurosciences and advanced medical imaging.
Some of this progress and other developments at Stony Brook Medicine — an entity that includes the School of Medicine, four other Health Science Schools, and Stony Brook University Hospital — have shown that we are set to soar as a medical enterprise. This issue details examples of our broadening clinical and educational programs by way of new leaders in Medicine, Cancer, Heart, Neurosciences, Research and other areas, and specialists that incorporate their expertise with the latest technologies to transform the lives of patients.
There are also plans for the development of other new buildings on campus, such as the creation of a Children’s Hospital facility and the addition of state-of-the-art imaging equipment for research and clinical services. We expect to broaden our collaboration with Brookhaven National Laboratory and draw from their faculty to strengthen research programs. New leadership will also spearhead significant growth and long-range goals for specific programs, such as the physically bringing together of clinical services and research of the Stony Brook University Cancer Center, a vital step toward obtaining National Cancer Institute (NCI) designation.
These are exciting times at Stony Brook Medicine. We hope that you share in this excitement and view our bold vision as one that allows us to soar into the future with results that benefit patients, students and faculty alike.
Kenneth Kaushansky, MD, MACP
Dean, School of Medicine